Vir Biotechnology (VIR) Leases (2020 - 2025)
Historic Leases for Vir Biotechnology (VIR) over the last 6 years, with Q3 2025 value amounting to $63.6 million.
- Vir Biotechnology's Leases rose 456.74% to $63.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $63.6 million, marking a year-over-year increase of 456.74%. This contributed to the annual value of $59.7 million for FY2024, which is 1615.86% down from last year.
- Vir Biotechnology's Leases amounted to $63.6 million in Q3 2025, which was up 456.74% from $64.9 million recorded in Q2 2025.
- Vir Biotechnology's Leases' 5-year high stood at $88.3 million during Q1 2022, with a 5-year trough of $57.6 million in Q3 2021.
- In the last 5 years, Vir Biotechnology's Leases had a median value of $70.3 million in 2024 and averaged $70.9 million.
- Its Leases has fluctuated over the past 5 years, first soared by 28996.07% in 2021, then crashed by 1690.55% in 2024.
- Vir Biotechnology's Leases (Quarter) stood at $87.2 million in 2021, then fell by 5.35% to $82.6 million in 2022, then fell by 13.78% to $71.2 million in 2023, then dropped by 16.16% to $59.7 million in 2024, then rose by 6.49% to $63.6 million in 2025.
- Its last three reported values are $63.6 million in Q3 2025, $64.9 million for Q2 2025, and $58.6 million during Q1 2025.